5443092025-07-012025-09-305443092025-09-305443092025-03-315443092025-04-012025-09-305443092025-07-012025-09-30in-capmkt:OtherExpenses1Member5443092025-04-012025-09-30in-capmkt:OtherExpenses1Member5443092025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15443092025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25443092025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15443092025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25443092025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15443092025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss25443092025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15443092025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss25443092025-07-012025-09-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares544309IKSNOTLISTEDINE115Q01022INVENTURUS KNOWLEDGE SOLUTIONS LIMITEDMain BoardEquity2025-04-012026-03-312025-10-302025-10-15INRMillionsQuarterlySecond quarterSingle segmentCARE ENABLEMENT PLATFORM PROVIDING TECHNOLOGY ENABLED SOLUTIONS TO HEALTHCARE PROVIDERS2025-10-3019:00:002025-10-3019:55:00trueCash Flow IndirectDeclaration of unmodified opinion2025-07-012025-09-30UnauditedConsolidated7810910000365500007847460000000407050000016149000030143000010227800005556200000229126000002291260000615450000-14556000046989000001821370000000-1418000018071900008710300002678220000170440000110.8110.580010.8110.58“Notes to the Statement of Unaudited Consolidated and Standalone Financial Results for the quarter and half year ended September 30, 2025" <BR> 1.The above standalone financial results of Inventurus Knowledge Solutions Limited ("the Company") and consolidated financial results of the Company and its subsidiaries (collectively "the Group") and its interest in associate for the quarter and half year ended September 30, 2025 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in it's meeting held on October 30, 2025. The above results for the quarter and half year ended September 30, 2025 have been reviewed by the Statutory Auditors of the Company in terms of Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. The figures for the quarter and half year ended September 30, 2024 as reported in the statement have been approved by the Company's Board of Directors but have not been subjected to limited review since the requirement of submission of quarterly financial results is applicable on listing of equity shares of the Company from the quarter ended December 31, 2024. <BR> <BR> 2.The statement has been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards("Ind AS") as prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder. <BR> <BR> 3.The Group operates in one reportable business segment which comprises a Care enablement platform providing technology enabled solutions to Healthcare providers. This in the context of Indian Accounting Standard (Ind AS 108) "Operating Segments", constitutes a single operating segment. <BR> <BR> 4.The Company has allotted 183,140 shares (period ended September 30, 2024 : 22,000 shares) for the quarter and 207,082 shares ( period ended September 30, 2024 :147,102 shares) for the half year ended September 30, 2025 to eligible employees on exercise of Employee Stock options, in accordance with the terms and conditions of the IKS Employees Stock Options Plan 2022 named 'IKS Health - ESOP Policy 2022' as approved by the shareholders of the Company on April 22, 2022. Further, during the quarter and half year ended September 30, 2025, the Company has granted 421,000 and 708,500 stock options respectively to eligible employees, as approved by the Nomination and Remuneration Committee. <BR> 5.The Board of Directors of the Company at its Meeting held on June 30, 2025, approved investment upto 17,000,000 USD by Inventurus Knowledge Solutions Inc, a subsidiary of the Company in IKS WWMG MSO LLC (“Target Company”) by subscribing upto 17,000,000 Common Units of the Target Company, which had resulted in acquisition of 48.02% of the outstanding equity interests of the Target Company by Inventurus Knowledge Solutions Inc. The contractual Purchase Closing Date was July 2, 2025 being the date on which Company had made the required payment as per the Purchase closing terms. <BR> <BR> 6.Earnings per share for the interim periods are not annualised. <BR> <BR> 7.The consolidated financial results of the Group include the results of its subsidiary companies viz: Inventurus Knowledge Solutions Inc, IKS Cares Foundation and its step down subsidiary companies viz: Aquity Holdings Inc, Aquity Solutions LLC, Aquity Solutions India Private Limited, Aquity Solutions Australia Pty Limited and Aquity Canada ULC and and its interest in associate. From the quarter ended September 30, 2025 the consolidated financial results includes share of profit/(loss) from IKS WWMG MSO LLC, being an associate company.2025-04-012025-09-30UnauditedConsolidated15211860000676800001527954000000080301200003422800005804600002086600000110394600004240080000042400800001187650000-28433000090332000003336760000000-1418000033225800009333100004255890000170440000119.8819.440019.8819.44Other Expenses1022780000Other Expenses2086600000424460000230300000124373000005663890000106430000003608240000185700000190900000140125000053860900001653100000915180000266094800000061920200002236320000546600000524150000900715000004482100009455360000003606484000017044000022237920000224083600002240836000041949700000009071500005102120000229640000143754000002868000067979800002221370000618000083105000083723000072736000037859600001729480000536430000806630000068585000000013656480000360648400003422600000-6366900000-91580000-9370000-4846200000058840000068029000015930000580460000001302000000-1805500000605500001847200004397000000023750000047988000047199600000007351600000398480000000014555400000000178000080010000000126390000000000000190900000000031690000050530000-176884000000627500000000001396130000156150000032922000000-18187500003972100003489000043210000018042200002236320000Remeasurement of post employment benefit obligations-21210000Changes in the fair value of equity investments at FVOCI931520000910310000Remeasurement of post employment benefit obligations-35460000Changes in the fair value of equity investments at FVOCI931520000896060000240670000236920000Gains/ (losses) on cash flow hedges (net)-372890000Exchange differences on translation of financial statements of foreign operations495430000122540000Gains/ (losses) on cash flow hedges (net)-304850000Exchange differences on translation of financial statements of foreign operations515010000210160000-78850000-64010000871030000933310000UnauditedtruePrice Waterhouse Chartered Accountants LLP true2026-11-30